308 related articles for article (PubMed ID: 16189158)
1. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions.
Bais AG; Beckmann I; Lindemans J; Ewing PC; Meijer CJ; Snijders PJ; Helmerhorst TJ
J Clin Pathol; 2005 Oct; 58(10):1096-100. PubMed ID: 16189158
[TBL] [Abstract][Full Text] [Related]
2. Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls.
Bais AG; Beckmann I; Ewing PC; Eijkemans MJ; Meijer CJ; Snijders PJ; Helmerhorst TJ
Mediators Inflamm; 2007; 2007():24147. PubMed ID: 18288269
[TBL] [Abstract][Full Text] [Related]
3. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix.
Sharma A; Rajappa M; Saxena A; Sharma M
Int J Gynecol Cancer; 2007; 17(4):879-85. PubMed ID: 17343606
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
Yang W; Song Y; Lu YL; Sun JZ; Wang HW
Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
[TBL] [Abstract][Full Text] [Related]
5. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
[TBL] [Abstract][Full Text] [Related]
6. Expression of p16
Badiga S; Chambers MM; Huh W; Eltoum IA; Piyathilake CJ
Cancer; 2016 Dec; 122(23):3615-3623. PubMed ID: 27479745
[TBL] [Abstract][Full Text] [Related]
7. [Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and interleukins 2, 4 and 6 (IL-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neoplasia: a preliminary report].
Pardo-Govea T; Callejas D; Núñez-Troconis J; Araujo M; Costa L; Pons H; Delgado M; Monsalve F
Invest Clin; 2005 Mar; 46(1):5-13. PubMed ID: 15782532
[TBL] [Abstract][Full Text] [Related]
8. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
[TBL] [Abstract][Full Text] [Related]
9. Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis.
Huang LW; Chao SL; Lee BH
J Clin Pathol; 2008 May; 61(5):627-31. PubMed ID: 18077768
[TBL] [Abstract][Full Text] [Related]
10. Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma.
Feng Q; Wei H; Morihara J; Stern J; Yu M; Kiviat N; Hellstrom I; Hellstrom KE
Gynecol Oncol; 2012 Nov; 127(2):412-9. PubMed ID: 22828962
[TBL] [Abstract][Full Text] [Related]
11. Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia.
Iwata T; Fujii T; Morii K; Saito M; Sugiyama J; Nishio H; Morisada T; Tanaka K; Yaguchi T; Kawakami Y; Aoki D
Int J Clin Oncol; 2015 Feb; 20(1):126-33. PubMed ID: 24578180
[TBL] [Abstract][Full Text] [Related]
12. Depressed type 1 cytokine synthesis by superantigen-activated CD4+ T cells of women with human papillomavirus-related high-grade squamous intraepithelial lesions.
Lee BN; Follen M; Shen DY; Malpica A; Adler-Storthz K; Shearer WT; Reuben JM
Clin Diagn Lab Immunol; 2004 Mar; 11(2):239-44. PubMed ID: 15013969
[TBL] [Abstract][Full Text] [Related]
13. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
14. Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix.
al-Saleh W; Giannini SL; Jacobs N; Moutschen M; Doyen J; Boniver J; Delvenne P
J Pathol; 1998 Mar; 184(3):283-90. PubMed ID: 9614381
[TBL] [Abstract][Full Text] [Related]
15. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer.
El-Sherif AM; Seth R; Tighe PJ; Jenkins D
J Pathol; 2001 Sep; 195(2):179-85. PubMed ID: 11592096
[TBL] [Abstract][Full Text] [Related]
17. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
18. Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia.
Tirone NR; Peghini BC; Barcelos AC; Murta EF; Michelin MA
Cancer Immunol Immunother; 2009 Dec; 58(12):2003-10. PubMed ID: 19381629
[TBL] [Abstract][Full Text] [Related]
19. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia.
Quek SC; Lim BK; Domingo E; Soon R; Park JS; Vu TN; Tay EH; Le QT; Kim YT; Vu BQ; Cao NT; Limson G; Pham VT; Molijn A; Ramakrishnan G; Chen J
Int J Gynecol Cancer; 2013 Jan; 23(1):148-56. PubMed ID: 23221730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
